zepbound and tirzepatide Zepbound® with Ivím Health's Weight Management Program FDA approval for Zepbound: FSU

In the case of GLP-1 medications, they activate receptors in the pancreas to release more insulin and reduce the release of glucagon (the hormone that raises blood sugar levels) to help blood sugar levels stay in a healthy range

The program operates in the standard telehealth GLP-1 space, working with semaglutide and tirzepatide either as FDA-approved brand products through a retail pharmacy or as compounded versions through a 503A compounding pharmacy

Every Dripology infusion is reviewed by a licensed provider

Payment alone does not advance medication fulfillment without a completed clinician review and prescription

They also delay gastric emptying, enhancing satiety and further reducing food consumption